The glioma-associated oncogene homolog 1 promotes epithelial-mesenchymal transition in human esophageal squamous cell cancer by inhibiting E-cadherin via Snail

Cancer Gene Therapy

Volumn 20, Issue 7, 2013, Pages 379-385

  Min, S ^a   Xiaoyan, X ^b   Fanghui, P ^a   Yamei, W ^a   Xiaoli, Y ^a   Feng, W ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

EMT; ESCC; GLI1; Invasion and metastasis; Snail

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN; VIMENTIN; ZINC FINGER PROTEIN;

ARTICLE; CANCER CELL CULTURE; CELL INVASION; CORRELATION ANALYSIS; EPITHELIAL MESENCHYMAL TRANSITION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NUCLEOLUS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR INVASION;

CADHERINS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; NEOPLASM INVASIVENESS; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; VIMENTIN;

ERINACEIDAE; GASTROPODA;

EID: 84880918191     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/cgt.2013.36     Document Type: Article

References (25)

1. Qi YJ, Chao WX, Chiu JF. An overview of esophageal squamous cell carcinoma proteomics. J Proteomics 2012; 75: 3129-3137.
2. Sun L, Yu S. Meta-analysis: non-steroidal anti-inflammatory drug use and the risk of esophageal squamous cell carcinoma. Dis Esophagus 2011; 24: 544-549.
3. Pan Y, Han J, Zhang Y, Li XJ. Role of vimentin in tumor metastasis and drug research. Sheng Li Ke Xue Jin Zhan 2010; 41: 413-416.
4. Theveneau E, Mayor R. Neural crest delamination and migration: from epitheliumto- mesenchyme transition to collective cell migration. Dev Biol 2012; 3661: 34-54.
5. Myong NH. Loss of E-cadherin and acquisition of vimentin in epithelialmesenchymal transition are noble indicators of uterine cervix cancer progression. Korean J Pathol 2012; 46: 341-348.
6. Smith BN, Odero-Marah VA. The role of Snail in prostate cancer. Cell Adh Migr 2012; 6: 433-441.
7. Matsuo N, Shiraha H, Fujikawa T, Takaoka N, Ueda N, Tanaka S et al. Twist expression promotes migration and invasion in hepatocellular carcinoma. BMC Cancer 2009; 18: 240.
8. Adam L, Zhong M, Choi W, Qi W, Nicoloso M, Arora A et al. miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy. Clin Cancer Res 2009; 15: 5060-5072.
9. Heldin CH, Vanlandewijck M, Moustakas A. Regulation of EMT by TGFb in cancer. FEBS Lett 2012; 586: 1959-1970.
10. Li Y, Maitah MY, Ahmad A, Kong D, Bao B, Sarkar FH. Targeting the Hedgehog signaling pathway for cancer therapy. Expert Opin Ther Targets 2012; 16: 49-66.
11. Barginear MF, Leung M, Budman DR. The hedgehog pathway as a therapeutic target for treatment of breast cancer. Breast Cancer Res Treat 2009; 116: 239-246.
12. Onishi H, Katano M. Hedgehog signaling pathway as a therapeutic target in various types of cancer. Cancer Sci 2011; 102: 1756-1760.
13. Katoh Y, Katoh M. Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation. Curr Mol Med 2009; 9: 873-886.
14. Lauth M, Toftgård R. Non-canonical activation of GLI transcription factors: implications for targeted anti-cancer therapy. Cell Cycle 2007; 6: 2458-2463. (Pubitemid 350058663)
15. Clement V, Sanchez P, de Tribolet N, Radovanovic I, Ruiz i Altaba A. HEDGEHOGGLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol 200723 17: 165-172.
16. Remmele W, Hildebrand U, Hienz HA, Klein PJ, Vierbuchen M, Behnken LJ et al. Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancer. Virchows Arch A Pathol Anal Histopathol 1986; 13: 127-147. (Pubitemid 16084979)
17. Javelaud D, Pierrat MJ, Mauviel A. Crosstalk between TGF-b and hedgehog signaling in cancer. FEBS Lett 2012; 586: 2016-2025.
18. Marini KD, Payne BJ, Watkins DN, Martelotto LG. Mechanisms of Hedgehog signalling in cancer. Growth Factors 2011; 29: 221-234.
19. Tiwari N, Gheldof A, Tatari M, Christofori G. EMT as the ultimate survival mechanism of cancer cells. Semin Cancer Biol 2012; 22: 194-207.
20. Rangel MC, Karasawa H, Castro NP, Nagaoka T, Salomon DS, Bianco C. Role of Cripto-1 during epithelial-to-mesenchymal transition in development and cancer. Am J Pathol 2012; 180: 2188-2200.
21. Hu YY, Zheng MH, Zhang R, Liang YM, Han H. Notch signaling pathway and cancer metastasis. Adv Exp Med Biol 2012; 727: 186-198.
22. Wells A, Yates C, Shepard CR. E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas. Clin Exp Metastasis 2008; 25: 621-628.
23. Katoh M. Epithelial-mesenchymal transition in gastric cancer (Review). Int J Oncol 2005; 27: 1677-1683.
24. Fearon ER. Connecting estrogen receptor function, transcriptional repression, and E-cadherin expression in breast cancer. Cancer Cell 2003; 3: 307-310. (Pubitemid 38340299)
25. Gloushankova NA. Changes in regulation of cell-cell adhesion during tumor transformation. Biochemistry (Mosc) 2008; 73: 742-750.